ArticleSurgical endoscopy2026
Safety of robotic hepatic parenchymal transection using scissor hepatectomy and alternative techniques: a cohort study.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Does complexity compromise outcomes in robotic hepatectomy?Surgical endoscopy · 2026Article
- Robotic right living donor hepatectomy with intermittent inflow occlusion: true clinical benefit or just another chapter in the ischemic preconditioning story?Translational gastroenterology and hepatology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundParenchymal transection represents a critical and challenging step in liver surgery. To date, there is no broadly accepted parenchymal transection technique in robotic liver surgery. This study aimed to compare the scissor hepatectomy technique to other parenchymal transection techniques.
methodsA prospective database comprising 243 consecutive patients who underwent robotic hepatectomies at a single center was reviewed. The cohort was divided based on whether they received robotic parenchymal transection via scissor hepatectomy or alternative transection techniques. Propensity score matching and logistic regression analyses were carried out.
resultsBetween 2020 and 2024, a total of 207 patients met the eligibility criteria with a median age of 64 years (55-70). Of these, 117 (57%) patients underwent parenchymal transection by scissor hepatectomy, while alternative transection techniques (including Bipolar, SynchroSeal, VesselSealer, Hydrojet, and CUSA) were utilized in 90 (43%) patients. SH was associated with lower intraoperative blood loss in both unmatched and matched groups (71 patients in each group). Postoperative Grade III or higher morbidity was comparable between groups (13% vs. 14%, p < 0.99). No risk factors were identified as being associated with Grade III or higher postoperative morbidity.
conclusionScissor hepatectomy is demonstrated to be a safe pure robotic parenchymal transection technique. Prospective randomized trials are warranted to compare this approach to other parenchymal transection techniques.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.